International Stem Cell CORP
ISCO OTC
SEC CIK 1355790
Follow International Stem Cell
Weekly email: filings, results, news
Revenue, last quarter
$2.7M
+9.3% vs same quarter last year
Net income
−$71K
−155% vs same quarter last year
EPS, diluted
−$0.01
−200% vs same quarter last year
Operating cash flow
$167K
+155.7% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $9.1M | −$418K |
| FY24 | $9.1M | −$209K |
| FY23 | $7.8M | −$131K |
| FY22 | $8.2M | −$331K |
| FY21 | $7.2M | −$899K |
| FY20 | $7.1M | −$2.7M |
| FY19 | $9.5M | −$4.3M |
| FY18 | $11.1M | −$2.1M |
| FY17 | $7.5M | −$6.1M |
| FY16 | $7.2M | −$1.1M |
| FY15 | $7.6M | −$2.6M |
| FY14 | $7M | −$12.5M |
| FY13 | $6.1M | −$10.5M |
| FY12 | $4.6M | −$9.8M |
| FY11 | $4.5M | −$9.2M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 55.7% | −2.9% | −4.6% |
| FY24 | 58.6% | −0.7% | −2.3% |
| FY23 | 59.2% | −8.5% | −1.7% |
| FY22 | 60% | −2.2% | −4% |
| FY21 | 59.1% | −26.8% | −12.5% |
| FY20 | 61% | −39.5% | −38.2% |
| FY19 | 58.5% | −60.5% | −45% |
| FY18 | 63.3% | −31.3% | −19.2% |
| FY17 | 71.5% | −66.3% | −81.4% |
| FY16 | 72.9% | −67.7% | −15.1% |
| FY15 | 72.8% | −60.4% | −34.9% |
| FY14 | 72.6% | −123.7% | −177.8% |
| FY13 | 73.3% | −122.8% | −170.5% |
| FY12 | 72.1% | −214.9% | −215.3% |
| FY11 | 64.3% | −250.6% | −202.4% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$35K |
| FY24 | −$153K |
| FY23 | $849K |
| FY22 | $331K |
| FY21 | −$1.3M |
| FY20 | −$369K |
| FY19 | −$1.6M |
| FY18 | −$1.3M |
| FY17 | −$2.3M |
| FY16 | −$4.4M |
| FY15 | −$4.2M |
| FY14 | −$6.7M |
| FY13 | −$5.8M |
| FY12 | - |
| FY11 | - |
- International Stem Cell
- Healthcare median
Show the numbers
| Year | International Stem Cell | Healthcare median |
|---|---|---|
| FY25 | −4.6% | 9.8% |
| FY24 | −2.3% | 10.5% |
| FY23 | −1.7% | 5.3% |
| FY22 | −4% | 12.7% |
| FY21 | −12.5% | 10.8% |
| FY20 | −38.2% | - |
| FY19 | −45% | - |
| FY18 | −19.2% | - |
| FY17 | −81.4% | - |
| FY16 | −15.1% | - |
| FY15 | −34.9% | - |
| FY14 | −177.8% | - |
| FY13 | −170.5% | - |
| FY12 | −215.3% | - |
| FY11 | −202.4% | - |
News
No stories filed under International Stem Cell yet - coverage appears here as the news feed clusters it.